Profile data is unavailable for this security.
About the company
Cardiff Lexington Corporation provides healthcare and financial services in the United States. The Company provides a full range of diagnostic and surgical services for injuries and disorders throughout the State of Florida with nine locations. The Company provides national tax resolution bookkeeping, and tax preparation services to individuals and companies that have federal and state tax liabilities. It also engages in real estate, developing 27 medium and high-density acres of dedicated riverfront property on the Salmon River, in Salmon, Idaho, adjacent to the Frank Church Wilderness Park, a wilderness park in the lower 48 states. Its portfolio of subsidiaries includes Nova Ortho & Spine, LLC, Platinum Tax Defenders, and Edge View Properties, Inc. Nova Ortho & Spine, LLC operates regional primary specialty and ancillary care facilities throughout Florida that provide traumatic injury victims with primary care evaluations, interventional pain management, and specialty consultation.
- Revenue in USD (TTM)7.22m
- Net income in USD-2.84m
- Incorporated2021
- Employees10.00
- LocationCardiff Lexington Corp3753 Howard Hughes Parkway, Suite 200LAS VEGAS 89169United StatesUSA
- Websitehttps://cardifflexington.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Elite Health Systems Inc | 0.00 | -1.18m | 21.73m | 2.00 | -- | 5.94 | -- | -- | -0.0938 | -0.0938 | 0.00 | 0.2106 | 0.00 | -- | -- | 0.00 | -45.56 | -14.62 | -49.63 | -19.89 | -- | -- | -- | -36.77 | -- | -- | 0.00 | -- | -- | -- | 38.97 | -- | -- | -- |
| Burning Rock Biotech Ltd (ADR) | 70.36m | -78.22m | 47.60m | 786.00 | -- | 0.5081 | -- | 0.6766 | -48.55 | -48.55 | 12.47 | 9.13 | 0.4331 | 1.97 | 2.68 | 89,513.99 | -48.15 | -37.09 | -65.09 | -45.29 | 67.71 | 70.02 | -111.18 | -123.88 | 2.85 | -- | 0.00 | -- | -4.58 | 20.81 | 32.69 | -- | -17.61 | -- |
| CRYO-CELL International, Inc. | 31.84m | -8.93m | 63.45m | 82.00 | -- | -- | -- | 1.99 | -1.08 | -1.08 | 3.86 | -1.19 | 0.4798 | 9.35 | 4.78 | 388,274.30 | -13.45 | 0.4686 | -18.45 | 0.7099 | 73.66 | 70.09 | -28.04 | 0.8133 | 0.5699 | -- | -- | -- | 3.32 | 1.41 | -443.57 | -- | 60.30 | -- |
| Exagen Inc | 55.75m | -16.93m | 73.02m | 174.00 | -- | 5.72 | -- | 1.31 | -0.9383 | -0.9383 | 3.09 | 0.7345 | 1.07 | -- | 4.22 | 320,408.00 | -32.39 | -30.21 | -39.53 | -33.75 | 58.80 | 54.86 | -30.36 | -55.36 | -- | -6.88 | 0.6148 | -- | 15.33 | 10.13 | 50.01 | -- | 33.00 | -- |
| 23andMe Holding Co. | 193.26m | -615.31m | 75.91m | 560.00 | -- | 0.7984 | -- | 0.3928 | -25.27 | -25.27 | 7.84 | 3.95 | 0.3451 | 6.93 | 198.52 | 345,107.20 | -109.86 | -- | -142.15 | -- | 46.51 | 46.35 | -318.39 | -121.63 | 1.14 | -- | 0.00 | -- | -26.66 | -13.01 | -113.92 | -- | -19.09 | -- |
| Cardiff Lexington Corp | 7.22m | -2.84m | 97.74m | 10.00 | 0.7895 | -- | -- | 13.54 | 8.23 | 3.61 | 0.9605 | 0.5838 | 0.3436 | -- | 0.542 | 722,096.00 | -9.27 | -- | -25.14 | -- | 49.32 | 62.01 | -26.98 | -- | -- | -0.0099 | 0.4916 | -- | -- | 39.71 | -- | -- | -- | -- |
| American Well Corp | 254.04m | -214.08m | 120.11m | 1.10k | -- | 0.356 | -- | 0.4728 | -14.54 | -14.54 | 17.22 | 22.02 | 0.4545 | 26.31 | 3.74 | 230,104.20 | -38.46 | -28.25 | -49.63 | -32.66 | 34.80 | 40.51 | -84.63 | -121.27 | 2.88 | -- | 0.00 | -- | -6.55 | 17.85 | -149.66 | -- | 51.49 | -- |
| Zomedica Corp | 26.73m | -62.19m | 128.57m | 144.00 | -- | 0.6338 | -- | 4.81 | -0.0635 | -0.0635 | 0.0273 | 0.207 | 0.1093 | 1.77 | 14.31 | 185,604.20 | -25.43 | -14.03 | -26.22 | -14.45 | 69.64 | -- | -232.70 | -220.98 | 10.15 | -- | 0.00 | -- | 33.05 | -- | -102.93 | -- | 89.85 | -- |
